CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...